1. Belgium Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
SOLVAC S.A.

SOLVAC S.A.

EEURONEXT:SOLV
85.50
EUR
-1.50
(-1.72%)
2.67BMarket Cap
SOLVAC S.A.
EURONEXT:SOLV
(Euronext)

Recent

price

85.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
33.37
4.35
10.16
4.72
1.15
5.66
8.89
15.35
12.68
1.5
-14.6
13.71
5.71
5.96
4.9
5.86
- -
Basic EPS, GAAP
4.46
3.14
4.72
4.96
4.84
4.07
5.01
5.19
5.43
5.66
5.47
5.61
5.85
-0.22
-0.14
-0.18
- -
Free Cash Flow per Basic Share
3.98
5.5
4.17
4.35
4.35
3.6
4.82
5.01
5.24
5.43
5.43
5.43
5.57
5.81
5.81
5.81
- -
Dividend per Share
131.9
129.46
126.74
144.45
135.5
146.48
151.34
150.32
163.41
148.54
114.62
136.89
118.49
118.64
117.73
117.78
118.64
Book Value per Share
111.26
108.86
106.06
123.77
114.82
130.48
135.3
134.27
147.37
132.49
98.57
120.84
118.49
118.64
117.73
117.78
118.64
Tangible Book Value per Share
17
17
17
17
17
21
21
21
21
21
21
21
21
21
21
21
21
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
553
72
168
78
19
121
190
328
271
32
-312
293
122
127
105
125
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-25
-24
-25
-17
-14
-17
-5
-3
-12
-9
-19
-18
-15
-12
-81
-30
-12
Working Capital
110
110
110
110
110
110
160
160
150
150
150
150
150
150
100
150
150
LT Debt
2,186
2,143
2,096
2,389
2,241
3,131
3,235
3,213
3,493
3,175
2,450
2,926
2,533
2,536
2,516
2,518
2,536
Total Equity
27.54
-0.04
7.63
3.2
0.81
4.25
5.64
-0.03
-0.03
-0.03
- -
-0.07
-0.07
- -
-0.11
-0.15
- -
Return on Invested Capital (%)
27.59
3.35
7.6
3.46
0.93
4.39
5.77
9.72
7.76
1.02
- -
10.25
4.27
- -
3.99
4.81
- -
Return on Capital (%)
28.95
3.33
7.93
3.48
0.82
4.5
5.97
10.17
8.08
0.96
-11.09
10.9
4.47
5.02
4.14
4.98
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'18
Jun'23
Dec'23
ST Debt
42
- -
49
LT Borrowings
150
- -
150
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
2,362
2,437
2,672

Working Capital

EUR

•

in mil. unless spec.
Dec'18
Jun'23
Dec'23
Total Current Assets
48
69
57
Cash, Cash Equivalents & STI
1
68
4
Accounts Receivable, Net
47
1
- -
Inventories
- -
- -
- -
Total Current Liabilities
60
5
69
Payables & Accruals
- -
- -
- -
ST Debt
42
- -
49
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.52%
1.08%
0.04%
Free Cash Flow
-7.19%
-20.83%
28.48%
Net Income, GAAP
-129.69%
-49.2%
19.69%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5.96
2024
- -
- -
4.9
2025
- -
- -
5.86

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5.81
2024
- -
- -
5.81
2025
- -
- -
5.81
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
Dow Inc. (NYSE:DOW)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Business
Solvac S.A. is a Belgian holding company primarily engaged in managing significant long-term strategic equity investments, notably a majority stake of approximately 30.8% in Solvay S.A., a global leader in advanced materials and specialty chemicals, and a substantial stake in Syensqo S.A., which also operates in specialty chemicals. Founded in 1983 and headquartered in Brussels, Solvac does not directly manufacture products but derives its core business from its portfolio holdings in manufacturing and marketing of specialty polymers, composite materials, soda ash, peroxides, silica, coatings, plastics, chemicals, and pharmaceutical products through these subsidiaries. The company's mission centers on supporting the sustainable growth and value creation of these invested entities, which serve end markets including automotive, aerospace, electronics, medical devices, and energy sectors worldwide. Recent developments include Solvac's ongoing role as a stable reference shareholder, facilitating strategic initiatives and growth in its portfolio companies, with no recent reports of new product launches directly by Solvac but significant shareholder activity and dividend announcements reflecting its financial health and strategic positioning as an investment vehicle in advanced materials and chemical industries. Solvac operates mainly in Belgium but its investment reach and market influence are global through its holdings. The company employs a minimal direct workforce, acting as a financial and strategic holding entity rather than an operational manufacturer. This structure positions Solvac as a key investor and stabilizing force within the specialty chemicals and advanced materials sectors, focusing on shareholder returns through its controlling interests and strategic oversight of its portfolio companies' innovation and expansion efforts.